ArticleBritish journal of clinical pharmacology2017

Utility of serum anti-cetuximab immunoglobulin E levels to identify patients at a high risk of severe hypersensitivity reaction to cetuximab.

Benoît Dupont et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.